INM – inmed pharmaceuticals inc. - common shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

INM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/19

12:12 am

inm

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 [Yahoo! Finance]

High Report

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 [Yahoo! Finance]

Report

9/23

08:08 pm

inm

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Low Report

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Report

9/23

08:50 am

inm

InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M [Seeking Alpha]

Medium Report

InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M [Seeking Alpha]

Report

9/16

01:39 pm

inm

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025

Low Report

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.